Main Sponsor – RGCC Europe N&W
For people with cancer seeking the very best personalised and integrated healthcare solutions. For clinicians wishing to access the most up to date cancer detection and monitoring tests.
Leading the Way in Personalised Medicine
RGCC Group was established in 2004 and is one of the most pioneering companies of the life science industry world-wide. The company specialises in the fields of medical genetics and, in particular, cancer genetics, chemo-sensitivity and chemo-resistance testing and in research and development within the pharmaceutical industry. The company headquarters are located in Switzerland, and our brand new, state-of-the-art facilities in northern Greece are equipped with the most up-to-date technologically advanced equipment and specialised software for data analysis.
RGCC is a global organization working in collaboration with branch offices and distributors to provide a world-wide service.
The activities of R.G.C.C. can be divided into two main sectors:
- Analytical services including detection, immune-phenotyping and isolation of circulating tumour cells using state of the art flow cytometers.
- Chemo-sensitivity and Chemo-resistance testing using micro-array technology
High throughput screening is used to provide an automated and fast method for sample processing as well as screening of different types of libraries, including combinatorial chemistry, genomics, protein and peptide libraries.
The laboratories of R.G.C.C. Group, meets international standards, certified by ISO Accreditation certification No.860-02